Commentary: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.
作者信息
Mendonça Guimarães Raphael, Barcellos Christovam, Gracie Renata, Xavier Diego Ricardo, Pedroso Marcel de Moraes, Magalhães Monica de Avellar Figueiredo Mafra
机构信息
Department of Social Sciences, National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Health Information Lab, Science and Technology Information and Communication Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
出版信息
Front Med (Lausanne). 2025 May 16;12:1558299. doi: 10.3389/fmed.2025.1558299. eCollection 2025.
Abstract
摘要
相似文献
1
Commentary: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.评论：巴西严重急性呼吸综合征病例中新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2025 May 16;12:1558299. doi: 10.3389/fmed.2025.1558299. eCollection 2025.
2
Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.巴西重症急性呼吸综合征病例中新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2024 Dec 18;11:1495428. doi: 10.3389/fmed.2024.1495428. eCollection 2024.
4
Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.巴西原住民中由严重急性呼吸综合征冠状病毒2感染或其他病原体引起的严重急性呼吸综合征：一项关于冠状病毒病（COVID）-19大流行第一年的观察性研究。
Lancet Reg Health Am. 2022 Apr;8:100177. doi: 10.1016/j.lana.2021.100177. Epub 2022 Jan 7.
5
Expression of concern: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.关注声明：巴西确诊为严重急性呼吸综合征病例的新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2025 Jan 15;12:1561115. doi: 10.3389/fmed.2025.1561115. eCollection 2025.
6
Retraction: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.撤稿声明：巴西重症急性呼吸综合征病例中新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2025 May 16;12:1619451. doi: 10.3389/fmed.2025.1619451. eCollection 2025.
7
15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study.15 个月的门诊后 COVID 综合征：特征、风险因素、结局和疫苗接种状况 - 纵向、观察性、病例对照研究。
Front Immunol. 2023 Sep 12;14:1226622. doi: 10.3389/fimmu.2023.1226622. eCollection 2023.
8
COVID-19 in patients with chronic kidney disease: a 2-year study of incidence and mortality in relation to the variants of concern waves in Brazil.COVID-19 与慢性肾脏病患者：巴西关注变异株相关的 2 年发病率和死亡率研究。
Trans R Soc Trop Med Hyg. 2023 Aug 3;117(8):606-608. doi: 10.1093/trstmh/trad019.
9
Mortality risk of Severe Acute Respiratory Syndrome cases classified as COVID-19: A longitudinal study.COVID-19 分类的严重急性呼吸综合征病例的死亡率：一项纵向研究。
PLoS One. 2024 Aug 30;19(8):e0309413. doi: 10.1371/journal.pone.0309413. eCollection 2024.
10
Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).SARS 和 2019 冠状病毒病（COVID-19）的甲状腺并发症。
Endocr J. 2021 Feb 28;68(2):129-136. doi: 10.1507/endocrj.EJ20-0443. Epub 2021 Jan 19.
本文引用的文献
1
Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.巴西重症急性呼吸综合征病例中新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2024 Dec 18;11:1495428. doi: 10.3389/fmed.2024.1495428. eCollection 2024.
2
Reckoning with COVID-19 denial: Brazil's exemplary model for global response.正视对新冠疫情的否认态度：巴西的全球应对典范模式。
World J Methodol. 2024 Sep 20;14(3):92512. doi: 10.5662/wjm.v14.i3.92512.
3
Avoidable COVID-19-related deaths and hospitalizations in Brazil, 2020-2023.2020-2023 年巴西可避免的与 COVID-19 相关的死亡和住院人数。
Vaccine. 2024 May 31;42(15):3437-3444. doi: 10.1016/j.vaccine.2024.04.041. Epub 2024 Apr 16.
4
The Brazilian primary health care response to the COVID-19 pandemic: individual and collective approaches.巴西初级卫生保健对 COVID-19 大流行的应对：个体和集体方法。
Front Public Health. 2023 Dec 8;11:1212584. doi: 10.3389/fpubh.2023.1212584. eCollection 2023.
5
Impact of sociodemographic factors on COVID-19 survival: a nationwide 2,000,000 in-patients' cohort in Brazil.社会人口因素对 COVID-19 存活的影响：巴西一项全国 200 万住院患者队列研究。
Rev Bras Epidemiol. 2023 Oct 30;26:e230050. doi: 10.1590/1980-549720230050. eCollection 2023.
6
Covid-19 Fiocruz Observatory - an analysis of the evolution of the pandemic from February 2020 to April 2022.Covid-19 Fiocruz 观察站——2020 年 2 月至 2022 年 4 月期间大流行演变的分析。
Cien Saude Colet. 2023 Oct;28(10):2845-2855. doi: 10.1590/1413-812320232810.10412023. Epub 2023 Jul 3.
7
[Evaluation of data on deaths due to COVID-19 from the databases of the Civil Registry (RC-Arpen), SIVEP-Gripe, and SIM in Brazil in 2020].[2020年巴西民事登记数据库（RC-Arpen）、流感监测信息系统（SIVEP-Gripe）和疾病信息系统（SIM）中新冠病毒病死亡数据评估]
Cad Saude Publica. 2023 Mar 31;39(3):e00077222. doi: 10.1590/0102-311XPT077222. eCollection 2023.
8
Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil.在巴西伽马变异株占主导地位的情况下，针对 COVID-19 进行最佳疫苗接种策略建模。
Vaccine. 2022 Nov 2;40(46):6616-6624. doi: 10.1016/j.vaccine.2022.09.082. Epub 2022 Oct 3.
9
Covid-19 Outbreak in Brazil: Health, Social, Political, and Economic Implications.巴西的新冠疫情爆发：健康、社会、政治和经济影响。
Int J Health Serv. 2022 Oct;52(4):442-454. doi: 10.1177/00207314221122658. Epub 2022 Sep 4.
10
How to overcome the stagnation of the first dose vaccine coverage curve against coronavirus disease 2019 in Brazil?如何克服巴西针对 2019 年冠状病毒病的第一剂疫苗覆盖率曲线停滞不前的问题？
Rev Soc Bras Med Trop. 2022 Jun 6;55:e0722. doi: 10.1590/0037-8682-0722-2021. eCollection 2022.
Zotero 插件